Contributions of human tumor xenografts to anticancer drug development.
about
Molecular profiling of patient-derived breast cancer xenograftsPatient-derived tumour xenografts as models for oncology drug developmentPatient-derived tumor xenografts: transforming clinical samples into mouse modelsMurine models to evaluate novel and conventional therapeutic strategies for cancerVEGF pathway targeting agents, vessel normalization and tumor drug uptake: from bench to bedsideContemporary murine models in preclinical astrocytoma drug developmentCurrent status and evolution of preclinical drug development models of epithelial ovarian cancerThe genomics and therapeutics of HER2-positive gastric cancer-from trastuzumab and beyondAssessment of a novel VEGF targeted agent using patient-derived tumor tissue xenograft models of colon carcinoma with lymphatic and hepatic metastasesDevelopment and histopathological characterization of tumorgraft models of pancreatic ductal adenocarcinomaTranslational validation of personalized treatment strategy based on genetic characteristics of glioblastomaHuman Organotypic Lung Tumor Models: Suitable For Preclinical 18F-FDG PET-ImagingUsing heterogeneity of the patient-derived xenograft model to identify the chemoresistant population in ovarian cancerHuman solid tumor xenografts in immunodeficient mice are vulnerable to lymphomagenesis associated with Epstein-Barr virus.The future of patient-derived tumor xenografts in cancer treatment.Cryopreservation of human colorectal carcinomas prior to xenografting.Self-assembled micelles of novel amphiphilic copolymer cholesterol-coupled F68 containing cabazitaxel as a drug delivery systemSide-population cells in luminal-type breast cancer have tumour-initiating cell properties, and are regulated by HER2 expression and signallingInhibition of tumor growth and angiogenesis by a lysophosphatidic acid antagonist in an engineered three-dimensional lung cancer xenograft model.Transcriptional dissection of pancreatic tumors engrafted in mice.Semi-automatic segmentation of subcutaneous tumours from micro-computed tomography images.Stability of preclinical models of aggressive renal cell carcinomas.Guidelines for the welfare and use of animals in cancer research.Bioluminescent orthotopic mouse models of human localized non-small cell lung cancer: feasibility and identification of circulating tumour cellsAnimal models of soft-tissue sarcoma.Preclinical efficacy of the c-Met inhibitor CE-355621 in a U87 MG mouse xenograft model evaluated by 18F-FDG small-animal PET.P-Rex1 is required for efficient melanoblast migration and melanoma metastasis.In-vivo fusion of human cancer and hamster stromal cells permanently transduces and transcribes human DNA.Tumor xenograft uptake of a pyrrole-imidazole (Py-Im) polyamide varies as a function of cell line grafted.A murine macrofilaricide pre-clinical screening model for onchocerciasis and lymphatic filariasisEstablishment of genetically diverse patient-derived xenografts of colorectal cancer.Quantifying the relative amount of mouse and human DNA in cancer xenografts using species-specific variation in gene lengthCyclic dermal BMP signalling regulates stem cell activation during hair regenerationAssessment of patient-derived tumour xenografts (PDXs) as a discovery tool for cancer epigenomics.The orthotopic xenotransplant of human glioblastoma successfully recapitulates glioblastoma-microenvironment interactions in a non-immunosuppressed mouse model.Establishment and characterization of patient-derived tumor xenograft using gastroscopic biopsies in gastric cancer.Development of a realistic in vivo bone metastasis model of human renal cell carcinomaNew concepts in breast cancer genomics and geneticsThe promise and challenge of ovarian cancer models.Establishment of patient-derived cancer xenografts in immunodeficient NOG mice.
P2860
Q21195204-57E51282-8104-4426-BA3F-7EBD96AAED52Q24604068-4528C99C-97F2-4F0D-8E12-E64DEBE033F1Q24627425-5DD90154-69CD-45EC-B054-CCD7958AA9B1Q24673595-21392185-8A00-4C68-8163-D86FC3BD02ABQ26770678-1E5F5DF6-1396-42D2-85DA-9DDFCCB6C728Q27026937-5BAFA737-0526-4B3E-AB55-44585332C9CAQ27028117-56313B31-10FF-479E-BC11-C5BA54B6C258Q28078788-66D50C0F-2F15-4723-B7B6-FC3912BA8331Q28478248-FA081634-1E3C-4B90-81DD-759368387E5EQ28534618-79F0419B-A231-43CE-A7D2-9389064BCB66Q28541502-03CF44DF-9041-4066-B494-2EE33DBDFB1DQ28553420-837B68CA-0576-4F7B-AE73-5F19F53F7A5BQ30409503-8A77EE3A-AA52-4210-8B5B-7B345F365124Q31068871-A7D061DF-84BA-4FDA-89E2-D609DAB150B4Q33361578-23274BC1-A4EE-4600-94D7-4E82C7CA38B6Q33628095-B742690C-BCD2-46AC-88E1-EBEC9243ECB8Q33633314-193D36EB-B941-4E1D-B619-A1A54C72316FQ33708119-10B36A58-13DA-4088-9D5B-32FACEB96ABDQ33759458-A882F690-F4E0-4EEF-9E3B-0BD3D21B4643Q33772571-B08A8D54-1F03-4931-8334-D5AA1993AB77Q33830411-F2968D44-E9DD-4B24-9BD8-75C31D3027EEQ33898564-05F3D846-D08E-4651-9DAD-A528513E381BQ33903753-8CC88B3A-942A-4134-B994-A92C2ED31BD8Q34055939-5609D2DB-1530-4BEC-90EB-C9B1DEDD36E1Q34098113-05AA19C2-589E-43B3-8307-C99575C5F781Q34164758-536512B0-CDF8-47AD-88CA-BD672D3AA899Q34235334-A1BC4146-3DA2-4154-A2EF-A6F35F27F52CQ34258171-308455DC-0FB9-468D-9402-7299AAFAD96FQ34394131-61D686AC-3DF0-4DC4-A25F-54DB13E816D8Q34416898-1B757A01-1BB6-42B0-ADF1-14C215C35FA0Q34704942-C269EF95-26A8-445C-8283-31446E31EE9EQ34729954-EA49393B-19DB-4E86-B917-01B3F1E148BDQ34737529-5ED547A7-6596-46DA-860D-E1168E796F93Q34937584-6562D1FA-38DB-4D44-A5D1-B8CB67B1EDF6Q34968805-53AC1092-8DD1-4DC0-B635-CC1744D672F7Q35119526-B5B07CA4-C73B-44F1-B4EC-14DD60F5C5C7Q35154534-7E954E83-3329-4E91-B8E1-82FB08639148Q35258057-9B3D7521-9319-4F4A-A08C-F15C90FD6AABQ35771750-DD5C5602-5457-46A0-B769-B9693922600EQ35798580-828056D3-B65F-4906-BCFF-2C7783976446
P2860
Contributions of human tumor xenografts to anticancer drug development.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Contributions of human tumor xenografts to anticancer drug development.
@ast
Contributions of human tumor xenografts to anticancer drug development.
@en
type
label
Contributions of human tumor xenografts to anticancer drug development.
@ast
Contributions of human tumor xenografts to anticancer drug development.
@en
prefLabel
Contributions of human tumor xenografts to anticancer drug development.
@ast
Contributions of human tumor xenografts to anticancer drug development.
@en
P1433
P1476
Contributions of human tumor xenografts to anticancer drug development.
@en
P2093
Angelika M Burger
Edward A Sausville
P304
3351-4, discussion 3354
P356
10.1158/0008-5472.CAN-05-3627
P407
P577
2006-04-01T00:00:00Z